BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 16509199)

  • 21. Re: Iori et al.: Bipolar transurethral resection of the prostate: clinical and urodynamic evaluation. (Urology 2008;71:252-255).
    De Nunzio C; Leonardo C
    Urology; 2008 Nov; 72(5):1188-9. PubMed ID: 18984146
    [No Abstract]   [Full Text] [Related]  

  • 22. A clinical outcomes and cost analysis comparing photoselective vaporization of the prostate to alternative minimally invasive therapies and transurethral prostate resection for the treatment of benign prostatic hyperplasia.
    Stovsky MD; Griffiths RI; Duff SB
    J Urol; 2006 Oct; 176(4 Pt 1):1500-6. PubMed ID: 16952668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. American Society of Anaesthesiologist Physical Status (ASA-PS): a predictor of treatment outcome of transurethral resection of the prostate (TURP).
    Basu S; Shivde S
    J R Coll Surg Edinb; 2000 Jun; 45(3):205. PubMed ID: 10881498
    [No Abstract]   [Full Text] [Related]  

  • 24. [Benign prostatic hyperplasia -- transurethral holmium-laser enucleation even in large prostate].
    Leyh H
    Aktuelle Urol; 2006 Jul; 37(4):257-8. PubMed ID: 16955958
    [No Abstract]   [Full Text] [Related]  

  • 25. Harmful gases including carcinogens produced during transurethral resection of the prostate and vaporization.
    Chung YJ; Lee SK; Han SH; Zhao C; Kim MK; Park SC; Park JK
    Int J Urol; 2010 Nov; 17(11):944-9. PubMed ID: 20880073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Advances in minimally invasive treatment of benign prostatic hyperplasia].
    Yu B; Wang Z
    Zhonghua Nan Ke Xue; 2007 Aug; 13(8):739-43. PubMed ID: 17918717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Commentary on holmium laser enucleation versus TURP.
    Kaplan SA
    J Urol; 2008 May; 179(5 Suppl):S91. PubMed ID: 18405766
    [No Abstract]   [Full Text] [Related]  

  • 28. [TUVRP and HOLEP as effective as TURP].
    Witte F
    Aktuelle Urol; 2007 Jan; 38(1):8-9. PubMed ID: 17354351
    [No Abstract]   [Full Text] [Related]  

  • 29. [Surgical treatment of benign prostatic hypertrophy].
    Dørflinger T; Frimodt-Møller C; Schou J
    Ugeskr Laeger; 2007 May; 169(20):1895-7. PubMed ID: 17553365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Holmium laser treatment of benign prostatic hyperplasia: an update.
    Matlaga BR; Miller NL; Lingeman JE
    Curr Opin Urol; 2007 Jan; 17(1):27-31. PubMed ID: 17143108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. mRNA expression analysis of human kallikrein 11 (KLK11) may be useful in the discrimination of benign prostatic hyperplasia from prostate cancer after needle prostate biopsy.
    Scorilas A; Gregorakis AK
    Biol Chem; 2006 Jun; 387(6):789-93. PubMed ID: 16800741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Established and novel options in the surgical treatment of lower urinary tract symptoms].
    Schlenker B; Gratzke C; Tilki D; Seitz M; Karl A; Stief CG; Reich O
    MMW Fortschr Med; 2009 Oct; 151(41):37-9; quiz 40. PubMed ID: 19891183
    [No Abstract]   [Full Text] [Related]  

  • 33. Enlarged prostate. Therapies have advanced.
    Mayo Clin Health Lett; 2004 Jan; 22(1):4-5. PubMed ID: 15002365
    [No Abstract]   [Full Text] [Related]  

  • 34. [Minimally invasive treatment of benign prostatic hyperplasia].
    Nørby B
    Ugeskr Laeger; 2004 Feb; 166(8):688-90. PubMed ID: 15042812
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of potassium-titanyl-phosphate laser vaporization of the prostate and transurethral resection of the prostate: update of a prospective non-randomized two-centre study.
    Ruszat R; Wyler SF; Seitz M; Lehmann K; Abe C; Bonkat G; Reich O; Gasser TC; Bachmann A
    BJU Int; 2008 Nov; 102(10):1432-8; discussion 1438-9. PubMed ID: 18671785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transurethral needle ablation of the prostate.
    Tubaro A; De Nunzio C; Miano R
    Curr Opin Urol; 2007 Jan; 17(1):7-11. PubMed ID: 17143104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Editorial comment on: thulium laser versus standard transurethral resection of the prostate: a randomized prospective trial.
    Seitz M
    Eur Urol; 2008 Feb; 53(2):390. PubMed ID: 17566638
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical relevance of transurethral resection of the prostate in "asymptomatic" patients with an elevated prostate-specific antigen level.
    van Renterghem K; Van Koeveringe G; Achten R; Van Kerrebroeck P
    Eur Urol; 2007 Sep; 52(3):819-26. PubMed ID: 17418482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomised trial comparing holmium laser enucleation versus transurethral resection in the treatment of prostates larger than 40 grams: results at 2 years.
    Wilson LC; Gilling PJ; Williams A; Kennett KM; Frampton CM; Westenberg AM; Fraundorfer MR
    Eur Urol; 2006 Sep; 50(3):569-73. PubMed ID: 16704894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and external validation of a highly accurate nomogram for the prediction of perioperative mortality after transurethral resection of the prostate for benign prostatic hyperplasia.
    Jeldres C; Isbarn H; Capitanio U; Zini L; Bhojani N; Shariat SF; Cloutier V; Lattouf JB; Duclos A; Jolivet-Tremblay M; Valiquette L; Saad F; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    J Urol; 2009 Aug; 182(2):626-32. PubMed ID: 19535100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.